Cyproheptadine Syrup and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Cyproheptadine Syrup and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyproheptadine
Brand name: Periactin
Synonyms: Cyproheptadine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyproheptadine Syrup-Insulin glargine, recombinant Subcutaneous
- Cyproheptadine Syrup-Insulin glulisine
- Cyproheptadine Syrup-Insulin Glulisine (Cartridges and Pens)
- Cyproheptadine Syrup-Insulin Glulisine (Vials)
- Cyproheptadine Syrup-Insulin glulisine Subcutaneous
- Cyproheptadine Syrup-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Cyproheptadine Tablets
- Insulin glargine and lixisenatide Subcutaneous-Cyramza
- Insulin glargine and lixisenatide Subcutaneous-Cyred
- Insulin glargine and lixisenatide Subcutaneous-Cyred EQ
- Insulin glargine and lixisenatide Subcutaneous-Cysto-Conray II
- Insulin glargine and lixisenatide Subcutaneous-Cystografin